resveratrol has been researched along with Brain Infarction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, R; Hou, Y; Wan, D; Wang, K; Ye, X; Zhou, Y | 1 |
| Hu, C; Pu, H; Su, Q | 1 |
| Chen, H; Jiang, Y; Li, C; Li, H; Yan, Z; Yang, J; Zhang, Z | 1 |
| Choi, JH; Koh, Y; Lee, H; Lim, YK; Park, EM; Shin, JA | 1 |
4 other study(ies) available for resveratrol and Brain Infarction
| Article | Year |
|---|---|
Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Brain; Brain Infarction; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Male; Neuroprotective Agents; Phosphoric Diester Hydrolases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Rolipram; Signal Transduction; Sirtuin 1; Stilbenes; Stroke | 2016 |
Neuroprotection by combination of resveratrol and enriched environment against ischemic brain injury in rats.
Topics: Analysis of Variance; Animals; Brain Edema; Brain Infarction; Brain Injuries; Disease Models, Animal; Environment; Hydrogen Peroxide; Infarction, Middle Cerebral Artery; Locomotion; Male; MAP Kinase Signaling System; Neurologic Examination; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2016 |
Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats.
Topics: Animals; Antioxidants; Brain; Brain Infarction; Disease Models, Animal; Ethanolamines; Excitatory Postsynaptic Potentials; Extracellular Fluid; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Hypothalamus; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Inhibitory Postsynaptic Potentials; Male; Neuroprotective Agents; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Treatment Outcome | 2010 |
Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke.
Topics: Acute Disease; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Immunologic; Female; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Reactive Oxygen Species; Resveratrol; Stilbenes; Stroke | 2010 |